Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 9, 2008 - Issue 16
Submit an article Journal homepage
175
Views
0
CrossRef citations to date
0
Altmetric
Review

Pharmacotherapy of pneumonia occurring in older patients

Miquel Falguera Universitat de Lleida, Hospital Universitari Arnau de Vilanova, Servei de Medicina Interna, Facultat de Medicina, Institut de Recerca Biomèdica de Lleida, Rovira Roure 80, 25198 Lleida, Spain +34 9732 48100; +34 9732 48754; [email protected]
, MD
Pages 2867-2879 | Published online: 20 Oct 2008

Bibliography

  • Ruiz M, Ewig S, Torres A, et al. Severe community-acquired pneumonia. Risk factors and follow-up epidemiology. Am J Respir Crit Care Med 1999;160:923-9
  • Díaz A, Barria P, Niederman M, et al. Etiology of community-acquired pneumonia in hospitalized patients in Chile. The increasing prevalence of respiratory viruses among classic pathogens. Chest 2007;131:779-87
  • Fernández-Sabe N, Carratalà J, Rosón B, et al. Community-acquired pneumonia in very elderly patients. Causative organisms, clinical characteristics, and outcomes. Medicine 2003;82:159-69
  • El-Solh AA, Sikka P, Ramadan F, Davies J. Etiology of severe pneumonia in the very elderly. Am J Respire Crit Care Med 2001;163:645-51
  • U.S. Interim Projections by Age, Sex, Race, and Hispanic Origin: 2000-2050. Available from: http://www.census.gov/ipc/www/usinterimproj
  • Almirall J, Bolíbar I, Vidal J, et al. Epidemiology of community-acquired pneumonia in adults: a population based study. Eur Respir J 2000;15:757-63
  • Janssens JP, Krause KH. Pneumonia in the very old. Lancet Infect Dis 2004;4:112-24
  • Riquelme R, Torres A, El-Ebiary M, et al. Community-acquired pneumonia in the elderly: a multivariate analysis of risk and prognostic factors. Am J Respir Crit Care Med 1996;154:1450-5
  • Metlay JP, Schulz R, Li YH, et al. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med 1977;157:1453-9
  • Cusack BJ. Pharmacokinetics in older persons. Am J Geriatr Pharmacother 2004;2:274-302
  • Turnheim K. When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol 2003;38:843-53
  • Hämmerlein A, Derendorf H, Lowenthal DT. Pharmacokinetic and pharmacodynamic changes in the elderly clinical implications. Clin Pharmacother 1999;35:49-64
  • Walter-Sack I, Klotz U. Influence of diet and nutritional status on drug metabolism. Clin Pharmacokinet 1996;31:47-64
  • Janssens JP, Pache JC, Nicod LP. Physiological changes in respiratory function associated with aging. Eur Respir J 1999;13:197-205
  • Castle SC, Uyemura K, Rafi A, et al. Comorbidity is a better predictor of impaired immunity than chronological age in older adults. J Am Geriatr Soc 2005;53:1565-9
  • Cabré M, Serra-Prat M, Force L, et al. Functional status as a risk factor for mortality in very elderly patients with pneumonia. Med Clin (Barc) 2008;131:167-70
  • Zalacaín R, Torres A, Celis R, et al. Community-acquired pneumonia in the elderly: Spanish multicentre study. Eur Respir J 2003;21:294-302
  • Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 2001;344:665-71
  • Holas MA, DePippo KI, Reding MJ. Aspiration and relative risk of medical complications following stroke. Arch Neurol 1994;51:1051-3
  • Murder RR. Pneumonia in residents of long-term care facilities: epidemiology, etiology, management, and prevention. Am J Med 1998;105:319-30
  • D´Agata E, Mitchell SL. Patterns of antimicrobial use among nursing home residents with advanced dementia. Arch Intern Med 2008;168:357-62
  • Kollef MH, Shorr A, Tabak YP, et al. Epidemiology and outcomes of health care-associated pneumonia. Results from a large US database of culture-positive pneumonia. Chest 2005;128:3854-62
  • Spaude KA, Abrutyn E, Kirchner C, et al. Influenza vaccination and risk of mortality among adults hospitalized with community-acquired pneumonia. Arch Intern Med 2007;167:53-9
  • Jackson ML, Nelson JC, Weiss NS, et al. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case–control study. Lancet 2008;372:398-405
  • Johnstone J, Marrie TJ, Euricj DT, Majumdar SR. Effect of pneumococcal vaccination in hospitalized adults with community-acquired pneumonia. Arch Intern Med 2007;167:1938-43
  • Mykietiuk A, Carratalà J, Domínguez A, et al. Effect of prior pneumococcal vaccination on clinical outcome of hospitalized adults with community-acquired pneumococcal pneumonia. Eur J Clin Microbiol Infect Dis 2006;25:457-62
  • Fisman DN, Aburtyn E, Spaude KA, et al. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia. Clin Infect Dis 2006;42:1093-101
  • Lexau CA, Lynfield R, Danila R, et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 2005;294:2043-51
  • de Roux A, Schmöele-Thoma B, Siber GR, et al. Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. Clin Infect Dis 2008;46:1015-23
  • Gulmez SE, Holm A, Frederiksen H, et al. Use of proton pump inhibitors and the risk of community-acquired pneumonia. A population-based case–control study. Arch Intern Med 2007;167:950-5
  • Ernst P, Suissa S. Pneumonia in elderly patients with chronic obstructive pulmonary disease. Curr Infect Dis Rep 2008;10:223-8
  • van de Garde EMW, Hak E, Souverein PC, et al. Statin treatment and reduced risk of pneumonia in patients with diabetes. Thorax 2006;61:957-61
  • Mortensen EM, Restrepo MI, Anzueto A, Pugh J. The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia. Respir Res 2005;6:82-8
  • van de Garde EM, Souverein PC, van den Bosch JM, et al. Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population. Eur Respir J 2006;27:1217-22
  • Etminan M, Zhang B, Fitzgerald M, Brophy JM. Do angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers decrease the risk of hospitalization secondary to community-acquired pneumonia? A nested case–control study. Pharmacotherapy 2006;26:479-82
  • Sopena N, Pedro-Botet L, Mateu L, et al. Community-acquired legionella pneumonia in elderly patients: characteristics and outcome. J Am Geriatr Soc 2007;55:114-9
  • García-Ordóñez MA, García-Jiménez JM, Páez F, et al. Clinical aspects and prognostic factors in elderly patients hospitalised for community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 2001;20:14-9
  • Alves dos Santos JW, Torres A, Michel GT, et al. Non-infectious and unusual infectious mimics of community-acquired pneumonia. Respir Med 2004;98:488-94
  • Ruiz M, Ewig S, Marcos MA, et al. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med 1999;160:397-405
  • Arancibia F, Bauer TT, Ewig S, et al. Community-acquired pneumonia due to Gram-negative bacilli and Pseudomonas aeruginosa: incidence, risk, and prognosis. Arch Intern Med 2002;162:1849-58
  • Falguera M, Carratalà J, Ruiz-González A, et al. Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli. Respirology In press.
  • Carratalà J, Rosón B, Fernández-Sevilla A, et al. Bacteremic pneumonia in neutropenic patients with cancer. Causes, empirical antibiotic therapy, and outcome. Arch Intern Med 1998;158:868-72
  • Thomsen RW, Hunborg HH, Lervang HH, et al. Risk of community-acquired pneumococcal bacteremia in patients with diabetes: a population-based case–control study. Diabetes Care 2004;27:1143-7
  • Akbar DH. Bacterial pneumonia: comparison between diabetics and non diabetics. Acta Diabetol 2001;38:77-82
  • Falguera M, Pifarré R, Martin M, et al. Etiology and outcome of community-acquired pneumonia in patients with diabetes mellitus. Chest 2005;128:3233-9
  • El-Solh AA, Pietrantoni C, Bhat A, et al. Microbiology of severe aspiration pneumonia in institutionalized elderly. Am J Respir Crit Care Med 2003;167:1650-4
  • Carratalà J, Mykietiuk A, Fernández-Sabe N, et al. Heath care-associated pneumonia requiring hospital admission. Epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med 2007;167:1393-9
  • Ruiz-González A, Falguera M, Nogués A, Rubio Caballero M. Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia. Am J Med 1999;106:385-90
  • Jennings LC, Anderson TP, Beynon KA, et al. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax 2008;63:42-48
  • Oner AF, Bay A, Arslan S, et al. Avian Influenza A (H5N1) infection in eastern Turkey in 2006. N Engl J Med 2006;355:2179-85
  • Falsey AR, Hennessey PA, Formica MA, et al. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005;352:1749-59
  • Boivin G, De Serres G, Hamelin ME, et al. An outbreak of severe respiratory tract infection due to human metapneumovirus in a long-term care facility. Clin Infect Dis 2007;44:1152-8
  • Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44:S27-72
  • Kollef MH, Morrow LE, Baughman RP, et al. Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes – Proceedings of the HCAP summit. Clin Infect Dis 2008;46:S296-334
  • Ruiz Montes F, Falguera M, Teixidó B, Rubio Caballero M. Clinical consequences of macrolide resistance in Streptococcus pneumoniae. Med Clin (Barc) 1990;94:758-9
  • Daneman N, McGeer A, Green K, Low DE. Macrolide resistance in bacteremic pneumococcal disease: implications for patient management. Clin Infect Dis 2006;43:432-8
  • Anzueto A, Niederman MS, Pearle J, et al. Community-acquired pneumonia recovery in the elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy. Clin Infect Dis 2006;42:73-81
  • Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-50
  • Lim WS, van der Eerden MM, Laing R, et al. Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58:377-82
  • Leff B, Burton L, Mader SL, et al. Comparison of stress experienced by family members of patients treated in hospital at home with that of those receiving traditional acute hospital care. J Am Geriatr Soc 2008;56:117-23
  • Leff B, Burton L, Mader S, et al. Satisfaction with hospital al home care. J Am Geriatr Soc 2006;54:1355-63
  • Menéndez R, Torres A, Zalacaín R, et al. Guidelines for the treatment of community-acquired pneumonia. Predictors of adherence and outcome. Am J Respir Crit Care Med 2005;172:757-62
  • Frei CR, Restrepo MI, Mortensen EM, Burgess DS. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia. Am J Med 2006;119:865-71
  • Dean NC, Bateman KA, Donnelly SM, et al. Improved clinical outcome with utilization of a community-acquired pneumonia guideline. Chest 2006;130:794-9
  • Hidron AI, Kourbatova EV, Halvosa JS, et al. Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage. Clin Infect Dis 2005;41:159-66
  • Barr B, Wilcox MH, Brady A, et al. Prevalence of methicillin-resistant Staphylococcus aureus colonization among older residents of care homes in the United Kingdom. Infect Control Hosp Epidemiol 2007;28:853-9
  • Pop-Vicas A, Mitchell SL, Kandel R, et al. Multidrug-resistant Gram-negative bacteria in a long-term facility: prevalence and risk factors. J Am Geriatr Soc 2008; In press
  • Rubinstein E, Kollef MH, Nathwani D. Pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008;46:S378-85
  • Metersky MI, Ma A, Houck PM, Bratzler DW. Antibiotics for bacteremic pneumonia. Improved outcomes with macrolides but not fluoroquinolones. Chest 2007;131:466-73
  • Waterer GW, Somes GW, Wunderick RG. Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Intern Med 2001;161:1837-42
  • García-Vidal C, Carratalà J. Current clinical management of legionnaires' disease. Expert Rev Anti Infect Ther 2006;4:995-1004
  • Sabrià M, Pedro-Botet ML, Gómez J, et al. Fluoroquinolones vs macrolides in the treatment of legionnaires disease. Chest 2005;128:1401-5
  • Theerthakarai R, El-Halees W, Ismail M, et al. Nonvalue of the initial microbiological studies in the management of nonsevere community-acquired pneumonia. Chest 2001;119:181-4
  • van der Eerden MM, Vlaspolder F, Graaff CS, et al. Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community-acquired pneumonia: a prospective randomised study. Thorax 2005;60:672-8
  • Guchev IA, Yu VL, Sinopalnikov A, et al. Management of nonsevere pneumonia in military trainees with the urinary antigen test for Streptococcus pneumoniae: an innovative approach to targeted therapy. Clin Infect Dis 2005;40:1608-16
  • Siempos II, Vardakas KZ, Kopterides P, Falagas ME. Adjunctive therapies for community-acquired pneumonia: a systematic review. J Antimicrob Chemother 2008; In press
  • Salluh JI, Póvoa P, Soares M, et al. The role of corticosteroids in severe community-acquired pneumonia: a systematic review. Crit Care 2008; In press
  • Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-39
  • Rodríguez-Julbe MC, Ramírez-Ronda CH, Arroyo E, et al. Antibiotics in older adults. P R Health Sci J 2004;23:25-33
  • Fontana RJ, Shakil AO, Greenson JK, et al. Acute liver failure due to amoxicillin and amoxicillin/clavulanate. Dig Dis Sci 2005;50:1785-90
  • Romanelli G, Cravarezza P, Pozzi A, et al. Carbapenems in the treatment of severe community-acquired pneumonia in hospitalized elderly patients: a comparative study against standard therapy. J Chemother 2002;14:609-17
  • Westphal JF. Macrolide-induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: un update focused on clarithromycin, azithromycin and dirithromycin. Br J Clin Pharmacol 2000;50:285-95
  • Rubinstein E. Comparative safety of the different macrolides. Int J Antimicrob Agents 2001;18:S71-6
  • Amsden GW, Kuye O, Wei GC. A study of the interaction potential of azithromycin and clarithromycin with atorvastatin in healthy volunteers. J Clin Pharmacol 2002;42:444-9
  • Shrader SP, Fermo JD, Dzikowski AL. Azithromycin and warfarin interaction. Pharmacotherapy 2004;24:945-9
  • Nicholson SC, Wilson WR, Naughton BJ, et al. Efficacy and safety of gatifloxacin in elderly outpatients with community-acquired pneumonia. Diagn Microbiol Infect Dis 2002;44:117-25
  • Shakeri-Nejad K, Stahlmann R. Drug interactions during therapy with three major groups of antimicrobial agents. Expert Opin Pharmacother 2006;7:639-51
  • Morganroth J, DiMarco JP, Anzueto A, et al. A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumonia. Chest 2005;128:3398-406
  • Carroll DN, Carroll DG. Interactions between warfarin and three commonly prescribed fluoroquinolones. Ann Pharmacother 2008;42:680-5
  • Okimoto N, Kibayashi T, Mimura K, et al. Clinical effect of gatifloxacin, 200 mg daily, on bacterial community-acquired pneumonia in the elderly. J Infect Chemother 2005;11:274-7
  • Houck PM, Bratzler DW, Nsa W, et al. Timing of antibiotic administration and outcomes for medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004;164:637-44
  • Welker JA, Huston M, McCue JD. Antibiotic timing and errors in diagnosing pneumonia. Arch Intern Med 2008;168:351-6
  • Li JZ, Winston LG, Moore DH, Bent S. Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis. Am J Med 2007;120:783-90
  • Shorr AF, Khashab MM, Xiang JX, et al. Levofloxacin 750-mg for 5 days for the treatment of hospitalized Fine risk class III/IV community-acquired pneumonia patients. Respir Med 2006;100:2129-36
  • Conte HA, Chen YT, Mehal W, et al. A prognostic rule for elderly patients admitted with community-acquired pneumonia. Am J Med 1999;106:20-8
  • Mody L, Sun R, Bradley SF. Assessment of pneumonia in older adults: effect of functional status. J Am Geriatr Soc 2006;54:1062-7
  • El-Solh AA, Aquilina AT, Dhillon RS, et al. Impact of invasive strategy on management of antimicrobial treatment failure in institutionalized older patients with severe pneumonia. Am J Respir Crit care Med 2002;166:1038-43
  • El-Solh AA, Brewer T, Okada M, et al. Indicators of recurrent hospitalization for pneumonia in the elderly. J Am Geriatr Soc 2004;52:2010-5
  • Low DE. Changing trends in antimicrobial-resistant pneumococci: it's not all bad news. Clin Infect Dis 2005;41:S228-33
  • Miyashita N, Saito A, Kohno S, et al. Multiplex PCR for the simultaneous detection of Chlamydia pneumoniae, Mycoplasma pneumoniae and Legionella pneumophila in community-acquired pneumonia. Respir Med 2004;98:542-50

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.